Exposure to alirocumab during the first trimester of pregnancy: A case report

2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk

(2019) François Mach et al.   EUROPEAN HEART JOURNAL

Statins and other lipid-lowering therapy and pregnancy outcomes in homozygous familial hypercholesterolaemia: A retrospective review of 39 pregnancies

(2018) Theunis C. Botha et al.   ATHEROSCLEROSIS

From mother to baby: antenatal exposure to monoclonal antibody biologics

(2018) Anne Pham-Huy et al.   Expert Review of Clinical Immunology

Survival in homozygous familial hypercholesterolaemia is determined by the on-treatment level of serum cholesterol

(2017) Gilbert R Thompson et al.   EUROPEAN HEART JOURNAL

Lipoprotein apheresis is essential for managing pregnancies in patients with homozygous familial hypercholesterolemia: Seven case series and discussion

(2016) Masatsune Ogura et al.   ATHEROSCLEROSIS

HEART UK statement on the management of homozygous familial hypercholesterolaemia in the United Kingdom

(2016) Michael France et al.   ATHEROSCLEROSIS

Statins and congenital malformations: cohort study

(2015) B. T. Bateman et al.   BMJ-British Medical Journal

Statins and congenital malformations: cohort study

(2015) B. T. Bateman et al.   BMJ-British Medical Journal

Integrated guidance on the care of familial hypercholesterolaemia from the International FH Foundation

(2014) Gerald F Watts et al.   European Journal of Preventive Cardiology